Pipeline PredictorRx™ evaluates new drugs, expected to have a significant clinical or financial impact.
Our Work

The changes enacted by the Patient Protection and Affordable Care Act are designed to substantially increase health insurance coverage. The authors analyze health care reform to assess the potential for increased insurance coverage among persons with disabilities.
This study seeks information about the prevalence, epidemiology, and management of self-injurious behavior by inmates in U.S. prison systems.
An article in the Ryan White Voices Caregiver Stories series that describes the experience as a nurse pratictioner treating patients when the AIDS epidemic began in the early 1980s.
This report provides a snapshot of the innovative programs we have initiated and conducted on behalf of the Commonwealth of Massachusetts. Our team has generated revenue and achieved cost avoidance totaling $26 billion over a 15-year period. Much can be accomplished when the family of state agencies in Massachusetts collaborate and combine their strengths to better serve the public.
Pipeline Trends features concise, impartial data on drugs in development and their potential place in therapy. This issue includes updates on aclidinium bromide, aflibercept, dimethyl fumarate, elvitegravir, and other new drugs.